Avicenna’s business model draws on the strengths of an excellent network that Avicenna and associate companies have formed. This network provides early and priority access to promising new compounds. Avicenna and it's associate companies are happy to assist you in locating and identifying suitable compounds for your product development pipelines on a fee-for-service basis. For more information, please contact our business development team or FOCUS IP - Innovative Products.
 

Contact:

FOCUS -  IP GmbH
Prof. Dr. Markus Meyer
CEO
Stresemannallee 6
D41460 Neuss, Germany

Phone: +49 2131 155 453
Fax:      +49 2131 155 229
Email:   markus.meyer(at)focus-ip.ch

or

Dr. Hanns-Christian Tillmann
Business Development & Licensing
Lörracherstrasse 50
4125 Riehen, Switzerland

Phone: +41 61 641 1645
Fax: +41 61 641 1677
Email: hanns-christian.tillmann(at)focus-ip.ch